PNPLA2 and cancer: Additionally, to determine whether targeting ATGL would effectively suppress pathways in human CCSC, we compared these DEGs representing colonospheres treated with atglistatin to DEGs from the publicly available transcriptome of human colonic tumor crypt base cells (relative to control) from cancer patients (GSE20916).